Prof. Dr. Maj. Gen. Hoang Van Luong, Deputy Director of the university,said after being injected, the volunteers are in stable conditions. Medicalworkers have asked them to update information about side effects if any on thee-Diary.
All volunteers are expected be fully vaccinated with twoshots in mid-August.
Nano Covax is developed by the Nanogen PharmaceuticalBiotechnology JSC based on recombinant DNA/protein technology. It went throughthe first-phase trial from December 18, 2020 and the second phase from February26, 2021. The third phase started on June 11, 2021.
Results from the first two trial phases showed that allvolunteers developed antibodies against the coronavirus SARS-CoV-2./.